Healthcare Sector Stocks
The Healthcare sector has a total of 1062 stocks, with a combined market cap of $8.4 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.73.
Market Cap
8.4T
Revenue
4.52T
Profits
201.27B
PE Ratio
41.73
Profit Margin
4.45%
Dividend Yield
0.42%
1062 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 809.84B | -1.89% | 4,232,300 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 574.86B | -0.60% | 6,463,061 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 368.65B | -0.05% | 5,951,772 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 310.93B | -1.55% | 1,657,819 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 291.20B | -1.72% | 7,686,292 | 65.01B |
| 6 | NVS | Novartis AG | 289.09B | -0.85% | 1,097,285 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 285.06B | -0.04% | 5,041,043 | 447.57B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 197.58B | 0.84% | 2,003,576 | 44.56B |
| 9 | AMGN | Amgen Inc. | 187.93B | -0.78% | 2,139,580 | 36.75B |
| 10 | ABT | Abbott Laboratories | 176.88B | 1.14% | 12,656,537 | 44.33B |
| 11 | NVO | Novo Nordisk A/S | 176.49B | 3.79% | 19,559,916 | 48.59B |
| 12 | GILD | Gilead Sciences, Inc. | 173.49B | -0.48% | 3,790,462 | 29.44B |
| 13 | ISRG | Intuitive Surgical, Inc. | 166.35B | 0.24% | 1,934,889 | 10.06B |
| 14 | PFE | Pfizer Inc. | 154.67B | 0.30% | 29,648,796 | 62.58B |
| 15 | DHR | Danaher Corporation | 140.22B | -0.24% | 3,180,363 | 24.57B |
| 16 | SYK | Stryker Corporation | 130.69B | -1.34% | 2,066,041 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 118.20B | -0.33% | 8,701,412 | 48.19B |
| 18 | SNY | Sanofi | 115.62B | 0.80% | 3,509,927 | 54.85B |
| 19 | GSK | GSK plc | 115.58B | -2.31% | 3,379,520 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 112.35B | -0.58% | 1,459,405 | 12.00B |
| 21 | MDT | Medtronic plc | 111.83B | -1.16% | 8,542,888 | 35.48B |
| 22 | HCA | HCA Healthcare, Inc. | 109.23B | -2.02% | 1,017,109 | 75.60B |
| 23 | MCK | McKesson Corporation | 105.76B | 0.07% | 465,586 | 397.96B |
| 24 | CVS | CVS Health Corporation | 96.11B | -3.39% | 8,660,837 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 96.02B | 1.24% | 12,030,039 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.37B | -0.21% | 570,689 | 14.34B |
| 27 | CI | The Cigna Group | 70.83B | -1.46% | 1,887,293 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 68.36B | -0.69% | 1,375,375 | 199.13B |
| 29 | MDLN | Medline Inc. | 62.97B | 0.55% | 4,503,792 | 28.43B |
| 30 | COR | Cencora, Inc. | 61.78B | -0.73% | 1,237,803 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.21B | - | 2,566,411 | 28.48B |
| 32 | ARGX | argenx SE | 52.12B | 1.51% | 262,226 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 50.78B | -0.29% | 2,209,942 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 49.85B | -1.45% | 1,337,435 | 244.67B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.13B | -0.56% | 354,717 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 45.09B | - | 5,128,466 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 44.28B | -0.13% | 2,660,114 | 21.92B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.22B | -1.77% | 799,050 | 3.71B |
| 39 | HLN | Haleon plc | 42.74B | -0.41% | 17,312,805 | 14.85B |
| 40 | ALC | Alcon Inc. | 39.50B | 0.99% | 1,522,251 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.81B | -0.50% | 3,318,608 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 35.48B | 3.21% | 196,133 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 33.85B | -0.51% | 2,035,636 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.54B | -1.55% | 3,159,283 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.19B | -0.82% | 1,280,523 | 5.40B |
| 46 | WAT | Waters Corporation | 32.02B | -1.44% | 673,369 | 3.17B |
| 47 | INSM | Insmed Incorporated | 31.67B | -4.34% | 2,227,889 | 606.42M |
| 48 | RVMD | Revolution Medicines, Inc. | 30.23B | 3.76% | 11,932,328 | - |
| 49 | IQV | IQVIA Holdings Inc. | 29.90B | 1.61% | 1,288,223 | 16.31B |
| 50 | NTRA | Natera, Inc. | 29.37B | -3.47% | 1,381,072 | 2.31B |
| 51 | RPRX | Royalty Pharma plc | 28.09B | -0.25% | 1,897,119 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 27.75B | - | 517,086 | 20.94B |
| 53 | VEEV | Veeva Systems Inc. | 27.33B | 5.16% | 2,709,392 | 3.20B |
| 54 | MTD | Mettler-Toledo International Inc. | 26.64B | -1.91% | 143,938 | 4.03B |
| 55 | BIIB | Biogen Inc. | 26.50B | 0.88% | 1,168,152 | 9.89B |
| 56 | UTHR | United Therapeutics Corporation | 25.31B | -0.17% | 491,461 | 3.18B |
| 57 | BNTX | BioNTech SE | 25.15B | 1.08% | 474,923 | 3.37B |
| 58 | HUM | Humana Inc. | 23.82B | 1.10% | 1,294,590 | 129.66B |
| 59 | DXCM | DexCom, Inc. | 23.68B | -2.24% | 5,682,845 | 4.66B |
| 60 | LH | Labcorp Holdings Inc. | 21.92B | -0.80% | 488,035 | 13.95B |
| 61 | STE | STERIS plc | 21.72B | -1.48% | 839,294 | 5.83B |
| 62 | MRNA | Moderna, Inc. | 21.52B | 2.69% | 4,805,492 | 1.94B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.19B | -1.41% | 877,972 | 11.04B |
| 64 | ROIV | Roivant Sciences Ltd. | 21.03B | 0.93% | 3,525,750 | 13.31M |
| 65 | ILMN | Illumina, Inc. | 20.09B | 1.49% | 1,461,609 | 4.34B |
| 66 | INCY | Incyte Corporation | 19.32B | -0.60% | 1,213,835 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 19.19B | -0.53% | 775,789 | 3.07B |
| 68 | CNC | Centene Corporation | 18.49B | 0.91% | 4,057,274 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 18.23B | -2.40% | 2,168,431 | 8.23B |
| 70 | GMAB | Genmab A/S | 17.83B | 0.83% | 949,888 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.83B | -1.55% | 1,258,870 | 21.31B |
| 72 | SMMT | Summit Therapeutics Inc. | 16.38B | 1.29% | 3,537,425 | - |
| 73 | VTRS | Viatris Inc. | 16.14B | -0.36% | 7,078,312 | 14.30B |
| 74 | BBIO | BridgeBio Pharma, Inc. | 15.06B | -0.30% | 1,562,847 | 502.08M |
| 75 | ASND | Ascendis Pharma A/S | 14.93B | -3.25% | 667,718 | 845.52M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.81B | -0.28% | 545,648 | 2.53B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 14.74B | -1.00% | 66,887 | - |
| 78 | SNN | Smith & Nephew plc | 14.64B | -0.38% | 844,328 | 6.16B |
| 79 | PODD | Insulet Corporation | 14.03B | 0.50% | 802,824 | 2.71B |
| 80 | COO | The Cooper Companies, Inc. | 13.71B | -1.84% | 1,673,638 | 4.15B |
| 81 | ALGN | Align Technology, Inc. | 13.36B | 1.00% | 785,824 | 4.03B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.19B | 0.48% | 1,098,029 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 13.07B | 0.08% | 346,414 | 1.40B |
| 84 | GMED | Globus Medical, Inc. | 12.79B | -0.41% | 1,038,364 | 2.94B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.69B | 0.08% | 1,288,363 | 943.71M |
| 86 | FMS | Fresenius Medical Care AG | 12.32B | -1.59% | 501,481 | 23.05B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.27B | -0.86% | 658,303 | 4.27B |
| 88 | SOLV | Solventum Corporation | 11.98B | 0.12% | 1,141,913 | 8.33B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | -1.22% | 226,347 | 958.40M |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.60B | -3.65% | 4,220,092 | 4.72B |
| 91 | ENSG | The Ensign Group, Inc. | 11.56B | -0.27% | 186,694 | 5.06B |
| 92 | EXEL | Exelixis, Inc. | 11.50B | -3.45% | 2,187,780 | 2.32B |
| 93 | GH | Guardant Health, Inc. | 11.13B | -1.78% | 1,478,244 | 982.02M |
| 94 | UHS | Universal Health Services, Inc. | 10.99B | -0.99% | 500,259 | 17.36B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.88B | -1.45% | 2,299,147 | 3.85B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.63B | -0.36% | 1,152,611 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.46B | -1.37% | 874,086 | 5.94B |
| 98 | RVTY | Revvity, Inc. | 10.39B | -0.65% | 550,671 | 2.86B |
| 99 | TEM | Tempus AI, Inc. | 10.11B | 13.89% | 12,467,211 | 1.27B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.94B | 6.39% | 2,202,175 | 1.09B |
| 101 | ABVX | ABIVAX Société Anonyme | 9.68B | -3.43% | 985,863 | 5.37M |
| 102 | DVA | DaVita Inc. | 9.65B | -3.27% | 844,424 | 13.64B |
| 103 | PRAX | Praxis Precision Medicines, Inc. | 9.47B | -1.07% | 514,408 | 7.46M |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.42B | - | 540,396 | 638.50M |
| 105 | BTSG | BrightSpring Health Services, Inc. | 9.39B | -0.07% | 1,856,293 | 12.91B |
| 106 | MASI | Masimo Corporation | 9.31B | - | 507,006 | 1.53B |
| 107 | TECH | Bio-Techne Corporation | 9.15B | -0.29% | 1,500,498 | 1.22B |
| 108 | BAX | Baxter International Inc. | 9.09B | 0.06% | 4,005,654 | 11.24B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.91B | 0.70% | 976,332 | 4.02B |
| 110 | ICLR | ICON Public Limited Company | 8.90B | 3.04% | 1,356,758 | 8.10B |
| 111 | HSIC | Henry Schein, Inc. | 8.88B | 0.28% | 869,349 | 13.18B |
| 112 | PCVX | Vaxcyte, Inc. | 8.70B | -3.68% | 1,076,228 | - |
| 113 | QGEN | Qiagen N.V. | 8.61B | -0.29% | 1,647,786 | 2.09B |
| 114 | ATR | AptarGroup, Inc. | 8.27B | -1.04% | 407,128 | 3.78B |
| 115 | NUVL | Nuvalent, Inc. | 8.24B | -0.26% | 619,067 | - |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.06B | 1.10% | 1,164,214 | 1.40B |
| 117 | CYTK | Cytokinetics, Incorporated | 8.05B | -1.48% | 1,259,874 | 88.04M |
| 118 | IBRX | ImmunityBio, Inc. | 8.03B | 2.37% | 10,524,603 | 113.29M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.99B | 1.28% | 208,831 | 2.58B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.90B | -0.54% | 246,237 | 389.13M |
| 121 | MOH | Molina Healthcare, Inc. | 7.65B | -0.48% | 1,478,315 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.44B | 0.69% | 850,440 | 738.26M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 7.27B | -0.97% | 389,992 | 39.21M |
| 124 | HQY | HealthEquity, Inc. | 7.07B | 2.84% | 766,916 | 1.31B |
| 125 | GKOS | Glaukos Corporation | 7.02B | 0.40% | 491,644 | 507.44M |
| 126 | GRFS | Grifols, S.A. | 6.95B | 2.24% | 377,851 | 8.83B |
| 127 | ACLX | Arcellx, Inc. | 6.75B | 0.10% | 588,887 | 22.29M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | 0.69% | 770,162 | 46.02M |
| 129 | BLTE | Belite Bio, Inc | 6.64B | -2.19% | 102,725 | - |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.60B | 0.96% | 764,982 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 3,588,666 | 15.00M |
| 132 | PTCT | PTC Therapeutics, Inc. | 6.09B | 0.70% | 568,764 | 1.73B |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.06% | 4,384,775 | - |
| 134 | BRKR | Bruker Corporation | 6.01B | -1.05% | 1,537,728 | 3.44B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | 0.61% | 427,309 | 189.76M |
| 136 | BLCO | Bausch + Lomb Corporation | 5.98B | 1.02% | 232,579 | 5.10B |
| 137 | CELC | Celcuity Inc. | 5.97B | 2.17% | 701,486 | - |
| 138 | CAI | Caris Life Sciences, Inc. | 5.92B | 3.76% | 1,880,995 | 812.03M |
| 139 | COGT | Cogent Biosciences, Inc. | 5.85B | -0.47% | 1,455,861 | - |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | -0.52% | 463,122 | 521.31M |
| 141 | CGON | CG Oncology, Inc. | 5.71B | 0.59% | 1,170,770 | 4.04M |
| 142 | SRRK | Scholar Rock Holding Corporation | 5.67B | -0.46% | 1,263,571 | - |
| 143 | AVTR | Avantor, Inc. | 5.66B | 2.07% | 16,308,236 | 6.55B |
| 144 | ERAS | Erasca, Inc. | 5.66B | 1.96% | 6,459,948 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 5.62B | -0.79% | 937,428 | 7.50M |
| 146 | TFX | Teleflex Incorporated | 5.58B | 0.90% | 775,219 | 1.99B |
| 147 | IMVT | Immunovant, Inc. | 5.58B | 3.31% | 1,579,786 | - |
| 148 | HIMS | Hims & Hers Health, Inc. | 5.54B | 13.72% | 45,577,948 | 2.35B |
| 149 | ALKS | Alkermes plc | 5.52B | -1.92% | 1,640,381 | 1.48B |
| 150 | PACS | PACS Group, Inc. | 5.48B | 5.13% | 705,824 | 5.29B |
| 151 | LNTH | Lantheus Holdings, Inc. | 5.45B | 1.45% | 753,369 | 1.54B |
| 152 | CRSP | CRISPR Therapeutics AG | 5.45B | -0.18% | 1,982,308 | 3.51M |
| 153 | SYRE | Spyre Therapeutics, Inc. | 5.42B | 7.78% | 4,199,093 | - |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.22B | -0.01% | 2,496,823 | 1.00B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | 0.90% | 709,265 | 2.04M |
| 156 | TGTX | TG Therapeutics, Inc. | 5.11B | 0.12% | 1,107,158 | 616.29M |
| 157 | CHE | Chemed Corporation | 5.07B | 0.32% | 218,477 | 2.53B |
| 158 | WAY | Waystar Holding Corp. | 4.73B | 10.03% | 3,669,465 | 1.10B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.67B | 0.50% | 840,677 | 761.41M |
| 160 | OSCR | Oscar Health, Inc. | 4.64B | 1.96% | 6,419,878 | 11.70B |
| 161 | SHC | Sotera Health Company | 4.57B | 0.63% | 2,914,959 | 1.16B |
| 162 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 4,927,184 | 634.21M |
| 163 | RDNT | RadNet, Inc. | 4.52B | 0.80% | 544,671 | 2.04B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.49B | -3.12% | 306,507 | 268.09M |
| 165 | OPCH | Option Care Health, Inc. | 4.45B | 1.58% | 2,352,938 | 5.65B |
| 166 | DOCS | Doximity, Inc. | 4.41B | 7.42% | 3,681,648 | 637.78M |
| 167 | NVST | Envista Holdings Corporation | 4.41B | -1.28% | 2,097,912 | 2.72B |
| 168 | MMED | MiniMed Group, Inc. | 4.27B | 0.07% | 1,065,143 | 2.89B |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.27B | -1.69% | 1,370,447 | 3.95B |
| 170 | MMSI | Merit Medical Systems, Inc. | 4.22B | 0.27% | 456,285 | 1.52B |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.16B | 0.05% | 739,802 | 7.70M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.16B | -0.53% | 1,346,123 | 3.02B |
| 173 | VKTX | Viking Therapeutics, Inc. | 4.11B | -0.20% | 1,690,639 | - |
| 174 | STVN | Stevanato Group S.p.A. | 4.02B | -0.20% | 279,700 | 1.39B |
| 175 | IRTC | iRhythm Holdings, Inc. | 4.02B | 0.96% | 270,949 | 747.14M |
| 176 | TMDX | TransMedics Group, Inc. | 3.98B | 0.37% | 405,733 | 605.49M |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.91B | -1.25% | 742,657 | 22.50M |
| 178 | GPCR | Structure Therapeutics Inc. | 3.84B | 1.94% | 1,091,868 | - |
| 179 | LEGN | Legend Biotech Corporation | 3.80B | 9.79% | 2,859,320 | 1.03B |
| 180 | TVTX | Travere Therapeutics, Inc. | 3.78B | -2.80% | 4,523,060 | 490.73M |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | -1.18% | 1,232,952 | 1.07B |
| 182 | BLLN | BillionToOne, Inc. | 3.71B | -2.63% | 557,473 | 305.11M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.62B | 1.63% | 1,242,836 | - |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.61B | 5.28% | 4,384,109 | 62.38M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.60B | -0.37% | 321,748 | 803.79M |
| 186 | LIVN | LivaNova PLC | 3.56B | 0.22% | 1,384,388 | 1.39B |
| 187 | LQDA | Liquidia Corporation | 3.54B | 3.64% | 943,710 | 158.32M |
| 188 | TWST | Twist Bioscience Corporation | 3.53B | 0.37% | 1,158,282 | 391.56M |
| 189 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.51B | -2.20% | 718,289 | 677.56M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.44B | 7.54% | 1,877,322 | - |
| 191 | BKD | Brookdale Senior Living Inc. | 3.35B | 1.08% | 2,501,162 | 3.05B |
| 192 | DYN | Dyne Therapeutics, Inc. | 3.30B | 0.86% | 2,629,630 | - |
| 193 | HNGE | Hinge Health, Inc. | 3.27B | 6.94% | 763,836 | 587.86M |
| 194 | ORKA | Oruka Therapeutics, Inc. | 3.25B | -2.25% | 1,402,788 | - |
| 195 | TXG | 10x Genomics, Inc. | 3.24B | 2.22% | 2,413,816 | 642.82M |
| 196 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.16B | -1.30% | 880,989 | 588.99M |
| 197 | ICUI | ICU Medical, Inc. | 3.15B | -1.28% | 231,846 | 2.23B |
| 198 | VERA | Vera Therapeutics, Inc. | 3.12B | -2.05% | 1,321,735 | - |
| 199 | ALMS | Alumis Inc. | 3.07B | 5.55% | 1,254,435 | 24.05M |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | -2.72% | 188,334 | 451.36M |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | -2.03% | 775,461 | 376.07M |
| 202 | BEAM | Beam Therapeutics Inc. | 3.05B | 1.25% | 1,847,424 | 139.74M |
| 203 | MANE | Veradermics, Incorporated | 3.01B | 7.35% | 545,712 | - |
| 204 | ITGR | Integer Holdings Corporation | 3.00B | -0.78% | 319,690 | 1.85B |
| 205 | RCUS | Arcus Biosciences, Inc. | 2.97B | 3.00% | 1,047,611 | 247.00M |
| 206 | PRVA | Privia Health Group, Inc. | 2.94B | 1.38% | 620,515 | 2.12B |
| 207 | WRBY | Warby Parker Inc. | 2.90B | 2.25% | 2,032,832 | 871.91M |
| 208 | CON | Concentra Group Holdings Parent, Inc. | 2.88B | -1.36% | 533,979 | 2.16B |
| 209 | HAE | Haemonetics Corporation | 2.88B | 2.43% | 530,090 | 1.32B |
| 210 | SUPN | Supernus Pharmaceuticals, Inc. | 2.88B | -0.34% | 349,023 | 718.95M |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 2.83B | -0.53% | 2,158,292 | 218.71M |
| 212 | RLAY | Relay Therapeutics, Inc. | 2.77B | 5.02% | 3,870,426 | 15.36M |
| 213 | PBH | Prestige Consumer Healthcare Inc. | 2.72B | 1.61% | 323,183 | 1.10B |
| 214 | SLNO | Soleno Therapeutics, Inc. | 2.72B | -0.10% | 5,203,432 | 190.41M |
| 215 | VCYT | Veracyte, Inc. | 2.70B | -0.76% | 559,520 | 517.15M |
| 216 | IRON | Disc Medicine, Inc. | 2.68B | -0.38% | 300,162 | - |
| 217 | CLDX | Celldex Therapeutics, Inc. | 2.66B | 1.62% | 971,613 | 1.55M |
| 218 | IMNM | Immunome, Inc. | 2.65B | 2.14% | 648,918 | 6.94M |
| 219 | ELVN | Enliven Therapeutics, Inc. | 2.63B | -2.01% | 865,774 | - |
| 220 | ZLAB | Zai Lab Limited | 2.62B | 5.87% | 1,401,823 | 460.16M |
| 221 | LMAT | LeMaitre Vascular, Inc. | 2.62B | -2.20% | 115,331 | 249.60M |
| 222 | KOD | Kodiak Sciences Inc. | 2.59B | -6.86% | 732,421 | - |
| 223 | HCM | HUTCHMED (China) Limited | 2.57B | 1.31% | 44,291 | 548.51M |
| 224 | LFST | LifeStance Health Group, Inc. | 2.55B | 0.61% | 1,145,308 | 1.42B |
| 225 | ADMA | ADMA Biologics, Inc. | 2.54B | 1.53% | 4,357,701 | 510.17M |
| 226 | MLYS | Mineralys Therapeutics, Inc. | 2.51B | 11.35% | 3,181,661 | - |
| 227 | HTFL | HeartFlow, Inc. | 2.51B | 0.62% | 1,090,505 | 176.03M |
| 228 | AAPG | Ascentage Pharma Group International | 2.49B | 5.45% | 2,041 | 82.08M |
| 229 | NHC | National HealthCare Corporation | 2.48B | -2.63% | 98,518 | 1.52B |
| 230 | RARE | Ultragenyx Pharmaceutical Inc. | 2.47B | 2.48% | 1,943,766 | 673.00M |
| 231 | ACHC | Acadia Healthcare Company, Inc. | 2.45B | 0.19% | 2,049,475 | 3.31B |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.40B | -1.39% | 3,003,224 | 3.68B |
| 233 | OGN | Organon & Co. | 2.40B | 5.86% | 9,638,394 | 6.22B |
| 234 | NKTR | Nektar Therapeutics | 2.39B | 2.41% | 532,452 | 55.23M |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.37B | -2.38% | 4,842,273 | 874.84M |
| 236 | GRDN | Guardian Pharmacy Services, Inc. | 2.35B | -1.85% | 331,539 | 1.45B |
| 237 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | -1.90% | 2,135,714 | 2.20B |
| 238 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | 0.03% | 948,992 | 276.98M |
| 239 | PAHC | Phibro Animal Health Corporation | 2.23B | -6.79% | 410,382 | 1.46B |
| 240 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 1,026,596 | 158.18M |
| 241 | DFTX | Definium Therapeutics, Inc. | 2.21B | 1.00% | 1,501,575 | - |
| 242 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -0.41% | 1,464,609 | 172.35M |
| 243 | BHC | Bausch Health Companies Inc. | 2.14B | 1.06% | 635,123 | 10.27B |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | -0.12% | 867,869 | 283.06M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.10B | -0.89% | 309,847 | 184.42M |
| 246 | NEOG | Neogen Corporation | 2.05B | -2.08% | 1,903,249 | 870.56M |
| 247 | ZYME | Zymeworks Inc. | 2.05B | 2.78% | 790,483 | 105.97M |
| 248 | GRAL | GRAIL, Inc. | 2.04B | -1.39% | 565,374 | 147.17M |
| 249 | SEM | Select Medical Holdings Corporation | 2.03B | - | 4,301,328 | 5.45B |
| 250 | SION | Sionna Therapeutics, Inc. | 2.03B | 4.13% | 768,534 | - |
| 251 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 3.45% | 572,152 | 54.03M |
| 252 | CAPR | Capricor Therapeutics, Inc. | 2.02B | 0.92% | 756,780 | 11.13M |
| 253 | MESO | Mesoblast Limited | 2.01B | 7.80% | 315,582 | 65.38M |
| 254 | RXRX | Recursion Pharmaceuticals, Inc. | 1.98B | 5.93% | 12,882,175 | 74.68M |
| 255 | WGS | GeneDx Holdings Corp. | 1.98B | 0.90% | 580,364 | 427.54M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 1.96B | -0.09% | 365,471 | 211.08M |
| 257 | ANAB | AnaptysBio, Inc. | 1.95B | -3.32% | 232,643 | 234.60M |
| 258 | OCUL | Ocular Therapeutix, Inc. | 1.94B | 1.71% | 2,555,046 | 51.95M |
| 259 | GLPG | Galapagos NV | 1.91B | 0.97% | 131,125 | 1.31B |
| 260 | PHVS | Pharvaris N.V. | 1.91B | 1.50% | 89,960 | - |
| 261 | AHG | Akso Health Group | 1.89B | -7.63% | 154,045 | 14.84M |
| 262 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.89B | 1.18% | 816,044 | -665.00K |
| 263 | TYRA | Tyra Biosciences, Inc. | 1.88B | -0.85% | 1,062,030 | - |
| 264 | PVLA | Palvella Therapeutics, Inc. | 1.84B | -0.69% | 165,302 | - |
| 265 | TRVI | Trevi Therapeutics, Inc. | 1.83B | 1.64% | 743,689 | - |
| 266 | AORT | Artivion, Inc. | 1.82B | -1.26% | 231,101 | 441.33M |
| 267 | AXGN | Axogen, Inc. | 1.80B | 0.87% | 652,969 | 225.21M |
| 268 | VCEL | Vericel Corporation | 1.80B | 0.65% | 364,323 | 276.26M |
| 269 | MD | Pediatrix Medical Group, Inc. | 1.80B | -1.86% | 574,069 | 1.91B |
| 270 | INVA | Innoviva, Inc. | 1.77B | -1.12% | 515,379 | 411.33M |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.76B | 1.08% | 2,708,553 | 67.67M |
| 272 | NRIX | Nurix Therapeutics, Inc. | 1.75B | 4.11% | 1,678,278 | 71.78M |
| 273 | RAPP | Rapport Therapeutics, Inc. | 1.75B | 1.55% | 207,637 | - |
| 274 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | -2.31% | 229,771 | 883.37M |
| 275 | ATEC | Alphatec Holdings, Inc. | 1.73B | -0.87% | 1,726,898 | 764.16M |
| 276 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 27.39% | 9,836,571 | 9.77M |
| 277 | AHCO | AdaptHealth Corp. | 1.72B | -0.94% | 1,536,447 | 3.24B |
| 278 | OMCL | Omnicell, Inc. | 1.71B | 3.30% | 395,012 | 1.18B |
| 279 | SGRY | Surgery Partners, Inc. | 1.69B | 0.92% | 688,668 | 3.31B |
| 280 | ADUS | Addus HomeCare Corporation | 1.69B | 0.10% | 146,680 | 1.42B |
| 281 | HRMY | Harmony Biosciences Holdings, Inc. | 1.69B | -0.24% | 549,796 | 868.45M |
| 282 | VIR | Vir Biotechnology, Inc. | 1.67B | 4.08% | 2,238,445 | 68.56M |
| 283 | NUVB | Nuvation Bio Inc. | 1.65B | -0.62% | 1,821,221 | 62.90M |
| 284 | SNDA | Sonida Senior Living, Inc. | 1.64B | 1.80% | 598,399 | 336.39M |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.63B | -0.33% | 746,779 | 911.98M |
| 286 | OCS | Oculis Holding AG | 1.63B | -0.22% | 147,405 | 1.51M |
| 287 | NBTX | Nanobiotix S.A. | 1.61B | 4.30% | 68,263 | 38.27M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.60B | -0.45% | 293,200 | - |
| 289 | IMCR | Immunocore Holdings plc | 1.60B | - | 142,811 | 400.02M |
| 290 | GENB | Generate Biomedicines, Inc. | 1.59B | -3.03% | 411,301 | 31.89M |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | 4.95% | 12,235,317 | 263.50M |
| 292 | PRGO | Perrigo Company plc | 1.57B | -0.52% | 2,055,494 | 4.25B |
| 293 | MBX | MBX Biosciences, Inc. | 1.57B | 0.46% | 317,860 | - |
| 294 | BHVN | Biohaven Ltd. | 1.56B | -0.67% | 1,960,812 | - |
| 295 | BCAX | Bicara Therapeutics Inc. | 1.55B | 3.22% | 736,821 | - |
| 296 | ARDX | Ardelyx, Inc. | 1.55B | -0.47% | 3,424,552 | 407.32M |
| 297 | VRDN | Viridian Therapeutics, Inc. | 1.52B | -2.04% | 1,367,813 | 70.85M |
| 298 | UFPT | UFP Technologies, Inc. | 1.51B | 0.10% | 149,718 | 602.80M |
| 299 | ATRC | AtriCure, Inc. | 1.49B | -0.10% | 687,463 | 534.53M |
| 300 | SVRA | Savara Inc. | 1.49B | -3.29% | 1,133,735 | - |
| 301 | IMTX | Immatics N.V. | 1.48B | 0.46% | 322,178 | 56.67M |
| 302 | AVAH | Aveanna Healthcare Holdings Inc. | 1.46B | 1.36% | 936,931 | 2.43B |
| 303 | ATAI | AtaiBeckley Inc. | 1.46B | 3.90% | 3,334,444 | 4.09M |
| 304 | GLUE | Monte Rosa Therapeutics, Inc. | 1.46B | 4.17% | 944,191 | 123.67M |
| 305 | ENOV | Enovis Corporation | 1.46B | 0.92% | 430,495 | 2.25B |
| 306 | PRCT | PROCEPT BioRobotics Corporation | 1.45B | 4.39% | 969,565 | 308.05M |
| 307 | ASTH | Astrana Health, Inc. | 1.45B | 0.55% | 291,839 | 3.18B |
| 308 | HROW | Harrow, Inc. | 1.44B | 2.35% | 372,892 | 272.30M |
| 309 | OLMA | Olema Pharmaceuticals, Inc. | 1.44B | 1.17% | 678,614 | - |
| 310 | WVE | Wave Life Sciences Ltd. | 1.43B | 2.71% | 3,461,444 | 42.73M |
| 311 | NVAX | Novavax, Inc. | 1.42B | 3.58% | 2,961,371 | 1.12B |
| 312 | TNDM | Tandem Diabetes Care, Inc. | 1.42B | -2.13% | 1,340,575 | 1.01B |
| 313 | NVCR | NovoCure Limited | 1.38B | 7.70% | 2,016,918 | 655.35M |
| 314 | PGEN | Precigen, Inc. | 1.38B | -2.01% | 2,671,796 | 9.68M |
| 315 | PGNY | Progyny, Inc. | 1.36B | 1.28% | 1,552,915 | 1.29B |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.35B | 1.29% | 412,798 | 1.84B |
| 317 | ARDT | Ardent Health, Inc. | 1.35B | 0.21% | 271,150 | 6.32B |
| 318 | PLSE | Pulse Biosciences, Inc. | 1.34B | -2.36% | 181,991 | 350.00K |
| 319 | MAZE | Maze Therapeutics, Inc. | 1.33B | -3.00% | 861,190 | 2.50M |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.30B | 6.40% | 594,386 | - |
| 321 | MLTX | MoonLake Immunotherapeutics | 1.29B | -4.05% | 1,075,493 | - |
| 322 | PHAR | Pharming Group N.V. | 1.27B | 0.68% | 4,125 | 376.13M |
| 323 | DBVT | DBV Technologies S.A. | 1.27B | -1.64% | 193,182 | 5.64M |
| 324 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | -0.92% | 961,882 | - |
| 325 | ZBIO | Zenas BioPharma, Inc. | 1.25B | -1.36% | 631,240 | 10.00M |
| 326 | BFLY | Butterfly Network, Inc. | 1.24B | 9.46% | 4,976,453 | 97.61M |
| 327 | STAA | STAAR Surgical Company | 1.22B | 1.23% | 782,992 | 239.44M |
| 328 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 0.49% | 263,857 | 1.30M |
| 329 | EYPT | EyePoint, Inc. | 1.22B | 2.02% | 589,932 | 31.37M |
| 330 | NNNN | Anbio Biotechnology | 1.21B | -4.65% | 32,915 | 8.65M |
| 331 | QDEL | QuidelOrtho Corporation | 1.19B | 0.98% | 1,827,150 | 2.73B |
| 332 | IRMD | IRADIMED CORPORATION | 1.19B | -0.55% | 53,864 | 83.81M |
| 333 | CNMD | CONMED Corporation | 1.19B | -0.73% | 371,348 | 1.37B |
| 334 | MPLT | MapLight Therapeutics, Inc. | 1.18B | -0.44% | 181,264 | - |
| 335 | KMTS | Kestra Medical Technologies, Ltd. | 1.18B | 2.28% | 214,395 | 83.72M |
| 336 | ABCL | AbCellera Biologics Inc. | 1.17B | 2.66% | 3,010,420 | 75.13M |
| 337 | SEPN | Septerna, Inc. | 1.16B | 7.46% | 816,060 | 45.95M |
| 338 | EVO | Evotec SE | 1.16B | 2.88% | 103,170 | 925.65M |
| 339 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -0.60% | 223,067 | 773.34M |
| 340 | AVNS | Avanos Medical, Inc. | 1.15B | 0.37% | 4,914,079 | 701.20M |
| 341 | AZTA | Azenta, Inc. | 1.15B | 2.84% | 813,097 | 595.03M |
| 342 | ALVO | Alvotech | 1.15B | 3.68% | 201,495 | 588.90M |
| 343 | IVA | Inventiva S.A. | 1.13B | 3.63% | 653,636 | 9.31M |
| 344 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -1.99% | 816,927 | 780.57M |
| 345 | NEO | NeoGenomics, Inc. | 1.13B | 3.95% | 1,361,586 | 727.33M |
| 346 | CLOV | Clover Health Investments, Corp. | 1.13B | 5.39% | 4,957,044 | 1.92B |
| 347 | INNV | InnovAge Holding Corp. | 1.11B | -0.24% | 222,311 | 915.37M |
| 348 | GERN | Geron Corporation | 1.08B | -4.52% | 21,002,960 | 183.88M |
| 349 | QURE | uniQure N.V. | 1.08B | 0.94% | 1,456,342 | 16.10M |
| 350 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | 2.06% | 1,037,650 | 291.85M |
| 351 | KALV | KalVista Pharmaceuticals, Inc. | 1.07B | 2.81% | 889,258 | 73.62M |
| 352 | PNTG | The Pennant Group, Inc. | 1.07B | -0.36% | 118,876 | 947.71M |
| 353 | GHRS | GH Research PLC | 1.05B | 1.37% | 69,657 | - |
| 354 | CMPX | Compass Therapeutics, Inc. | 1.05B | 7.54% | 3,192,236 | 850.00K |
| 355 | URGN | UroGen Pharma Ltd. | 1.05B | 1.37% | 816,549 | 109.79M |
| 356 | CRON | Cronos Group Inc. | 1.03B | 5.84% | 1,664,054 | 146.59M |
| 357 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | -2.37% | 1,775,701 | - |
| 358 | BLFS | BioLife Solutions, Inc. | 1.02B | 4.54% | 334,662 | 96.21M |
| 359 | ANNX | Annexon, Inc. | 1.02B | 9.48% | 4,339,557 | - |
| 360 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | 0.95% | 501,705 | 175.11M |
| 361 | AKTS | Aktis Oncology, Inc. | 999.94M | 1.40% | 150,331 | 6.50M |
| 362 | TDOC | Teladoc Health, Inc. | 999.59M | 5.73% | 5,750,295 | 2.53B |
| 363 | CTMX | CytomX Therapeutics, Inc. | 985.77M | 0.44% | 4,731,694 | 76.20M |
| 364 | AMPH | Amphastar Pharmaceuticals, Inc. | 983.63M | 1.40% | 389,357 | 719.89M |
| 365 | SSII | SS Innovations International, Inc. | 979.71M | 0.20% | 37,737 | 42.48M |
| 366 | EVMN | Evommune, Inc. | 970.33M | 1.16% | 181,138 | 13.00M |
| 367 | JBIO | Jade Biosciences, Inc. | 949.83M | -0.93% | 289,451 | - |
| 368 | PCRX | Pacira BioSciences, Inc. | 948.68M | -1.35% | 517,625 | 726.41M |
| 369 | CERT | Certara, Inc. | 942.95M | 5.67% | 2,201,427 | 418.84M |
| 370 | FTRE | Fortrea Holdings Inc. | 939.68M | 4.80% | 1,196,291 | 2.72B |
| 371 | SANA | Sana Biotechnology, Inc. | 918.02M | -1.15% | 4,277,663 | - |
| 372 | XNCR | Xencor, Inc. | 917.47M | - | 978,348 | 125.58M |
| 373 | MGTX | MeiraGTx Holdings plc | 916.27M | -0.35% | 698,502 | 81.39M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 915.93M | -4.60% | 962,756 | 1.02B |
| 375 | SDGR | Schrödinger, Inc. | 915.43M | 4.11% | 1,758,463 | 255.87M |
| 376 | JANX | Janux Therapeutics, Inc. | 914.91M | -1.31% | 987,578 | 10.00M |
| 377 | CGEM | Cullinan Therapeutics, Inc. | 904.87M | 4.18% | 977,811 | - |
| 378 | INMD | InMode Ltd. | 902.86M | 0.78% | 660,872 | 370.50M |
| 379 | CDNA | CareDx, Inc. | 899.87M | -0.34% | 594,175 | 379.81M |
| 380 | MRVI | Maravai LifeSciences Holdings, Inc. | 899.74M | 6.71% | 1,751,123 | 185.74M |
| 381 | OPK | OPKO Health, Inc. | 895.70M | 0.85% | 1,101,749 | 606.88M |
| 382 | OMER | Omeros Corporation | 881.95M | 3.46% | 1,158,627 | - |
| 383 | SLS | SELLAS Life Sciences Group, Inc. | 881.75M | 1.03% | 2,670,212 | - |
| 384 | BVS | Bioventus Inc. | 878.11M | 6.56% | 831,512 | 568.09M |
| 385 | ABUS | Arbutus Biopharma Corporation | 875.74M | 2.99% | 3,279,823 | 14.08M |
| 386 | DRUG | Bright Minds Biosciences Inc. | 869.15M | 0.54% | 107,485 | - |
| 387 | TALK | Talkspace, Inc. | 863.78M | - | 2,179,059 | 228.87M |
| 388 | IART | Integra LifeSciences Holdings Corporation | 859.65M | -0.27% | 1,028,490 | 1.64B |
| 389 | TBPH | Theravance Biopharma, Inc. | 856.84M | 0.24% | 349,321 | 107.46M |
| 390 | MNKD | MannKind Corporation | 855.36M | 1.09% | 3,212,299 | 348.97M |
| 391 | VOR | Vor Biopharma Inc. | 845.30M | -1.70% | 881,944 | - |
| 392 | SGP | SpyGlass Pharma, Inc. | 826.64M | 0.86% | 28,127 | - |
| 393 | SLDB | Solid Biosciences Inc. | 818.62M | 1.09% | 933,974 | - |
| 394 | ANRO | Alto Neuroscience, Inc. | 813.65M | -1.36% | 341,360 | - |
| 395 | TLRY | Tilray Brands, Inc. | 807.78M | 0.58% | 2,912,884 | 858.28M |
| 396 | KURA | Kura Oncology, Inc. | 799.38M | -0.98% | 874,516 | 67.48M |
| 397 | SPRY | ARS Pharmaceuticals, Inc. | 796.36M | -1.47% | 1,593,729 | 84.28M |
| 398 | GDRX | GoodRx Holdings, Inc. | 794.77M | 4.04% | 1,839,889 | 796.85M |
| 399 | LXRX | Lexicon Pharmaceuticals, Inc. | 788.05M | 6.29% | 2,133,509 | 49.80M |
| 400 | DSGN | Design Therapeutics, Inc. | 786.32M | 0.75% | 428,276 | - |
| 401 | OMDA | Omada Health, Inc. | 773.10M | 5.30% | 816,100 | 260.21M |
| 402 | CBLL | CeriBell, Inc. | 772.77M | 5.01% | 265,941 | 89.06M |
| 403 | CMPS | COMPASS Pathways plc | 768.38M | 3.65% | 2,237,263 | - |
| 404 | FBRX | Forte Biosciences, Inc. | 765.68M | -3.52% | 214,410 | - |
| 405 | NUTX | Nutex Health Inc. | 759.55M | 1.08% | 259,040 | 875.26M |
| 406 | BIOA | BioAge Labs, Inc. | 753.12M | 2.41% | 392,124 | 9.00M |
| 407 | RLMD | Relmada Therapeutics, Inc. | 753.10M | -0.14% | 1,268,260 | - |
| 408 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 751.51M | 2.29% | 535,984 | - |
| 409 | AMN | AMN Healthcare Services, Inc. | 748.77M | 3.14% | 531,160 | 2.73B |
| 410 | CSTL | Castle Biosciences, Inc. | 745.89M | 1.03% | 196,046 | 344.23M |
| 411 | LBRX | LB Pharmaceuticals Inc | 736.71M | 9.60% | 744,558 | - |
| 412 | ETON | Eton Pharmaceuticals, Inc. | 735.86M | -0.55% | 353,146 | 79.95M |
| 413 | GYRE | Gyre Therapeutics, Inc. | 732.34M | 2.30% | 62,401 | 116.59M |
| 414 | IRWD | Ironwood Pharmaceuticals, Inc. | 712.56M | 8.17% | 2,725,720 | 296.15M |
| 415 | TENX | Tenax Therapeutics, Inc. | 704.71M | -5.21% | 614,834 | - |
| 416 | ARVN | Arvinas, Inc. | 701.65M | -0.27% | 607,058 | 262.60M |
| 417 | EHAB | Enhabit, Inc. | 695.42M | -1.65% | 1,776,053 | 1.06B |
| 418 | PSNL | Personalis, Inc. | 694.01M | -0.75% | 1,491,591 | 69.65M |
| 419 | DRTS | Alpha Tau Medical Ltd. | 693.52M | 0.64% | 271,630 | - |
| 420 | PRME | Prime Medicine, Inc. | 671.13M | 2.43% | 2,173,787 | 4.63M |
| 421 | CBIO | Crescent Biopharma, Inc. | 662.62M | 2.20% | 229,297 | 10.84M |
| 422 | OCGN | Ocugen, Inc. | 658.90M | 8.33% | 5,999,309 | 4.41M |
| 423 | BWAY | BrainsWay Ltd. | 650.12M | 5.61% | 224,739 | 52.23M |
| 424 | SIBN | SI-BONE, Inc. | 639.96M | 0.42% | 641,427 | 200.93M |
| 425 | HSTM | HealthStream, Inc. | 617.66M | 3.44% | 223,696 | 304.06M |
| 426 | PROK | ProKidney Corp. | 606.85M | 5.24% | 2,818,690 | 893.00K |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 605.90M | 5.41% | 731,798 | 106.47M |
| 428 | CTKB | Cytek Biosciences, Inc. | 602.90M | 1.52% | 306,575 | 201.49M |
| 429 | RIGL | Rigel Pharmaceuticals, Inc. | 592.25M | 2.13% | 382,226 | 294.28M |
| 430 | AVR | Anteris Technologies Global Corp. | 587.88M | - | 460,587 | 1.91M |
| 431 | EIKN | Eikon Therapeutics, Inc. | 586.86M | 2.17% | 311,849 | - |
| 432 | PRTA | Prothena Corporation plc | 582.47M | 1.98% | 409,897 | 9.68M |
| 433 | BBNX | Beta Bionics, Inc. | 580.19M | 10.25% | 2,237,916 | 100.25M |
| 434 | TCMD | Tactile Systems Technology, Inc. | 576.72M | 1.16% | 205,622 | 329.52M |
| 435 | MDXG | MiMedx Group, Inc. | 576.44M | -1.02% | 1,063,023 | 418.63M |
| 436 | CRMD | CorMedix Inc. | 571.53M | -0.96% | 1,079,583 | 311.71M |
| 437 | EMBC | Embecta Corp. | 569.10M | 1.59% | 512,852 | 1.08B |
| 438 | KYTX | Kyverna Therapeutics, Inc. | 568.28M | 0.43% | 600,685 | - |
| 439 | TECX | Tectonic Therapeutic, Inc. | 557.48M | -0.87% | 169,348 | - |
| 440 | ESPR | Esperion Therapeutics, Inc. | 557.28M | 5.85% | 16,494,188 | 403.14M |
| 441 | LYEL | Lyell Immunopharma, Inc. | 556.15M | 2.01% | 86,964 | 36.00K |
| 442 | VSTM | Verastem, Inc. | 556.05M | 3.09% | 2,016,995 | 30.91M |
| 443 | ADCT | ADC Therapeutics SA | 555.18M | 13.21% | 2,733,498 | 81.36M |
| 444 | PHR | Phreesia, Inc. | 550.51M | 5.35% | 1,731,066 | 480.59M |
| 445 | FULC | Fulcrum Therapeutics, Inc. | 549.45M | 4.43% | 705,832 | 80.00M |
| 446 | ACRS | Aclaris Therapeutics, Inc. | 546.25M | 0.26% | 1,254,257 | 7.83M |
| 447 | STTK | Shattuck Labs, Inc. | 541.92M | 5.75% | 342,806 | 1.00M |
| 448 | ZURA | Zura Bio Limited | 539.87M | -0.52% | 478,904 | - |
| 449 | UPB | Upstream Bio, Inc. | 537.67M | -4.45% | 552,409 | 2.85M |
| 450 | VALN | Valneva SE | 536.99M | -0.99% | 87,154 | 205.07M |
| 451 | IMMX | Immix Biopharma, Inc. | 532.24M | 1.93% | 617,419 | - |
| 452 | ALLO | Allogene Therapeutics, Inc. | 529.00M | -4.82% | 74,098,680 | 22.00K |
| 453 | NPCE | NeuroPace, Inc. | 525.54M | 1.69% | 126,358 | 99.99M |
| 454 | ENGN | enGene Therapeutics Inc. | 519.84M | 2.11% | 211,274 | - |
| 455 | AGMB | AgomAb Therapeutics NV | 519.53M | 1.81% | 213,755 | - |
| 456 | AQST | Aquestive Therapeutics, Inc. | 517.47M | 2.17% | 885,196 | 44.55M |
| 457 | OFIX | Orthofix Medical Inc. | 516.66M | 1.18% | 312,708 | 822.31M |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 459 | LXEO | Lexeo Therapeutics, Inc. | 503.79M | 1.95% | 608,611 | - |
| 460 | TRDA | Entrada Therapeutics, Inc. | 503.64M | -0.29% | 79,158 | 25.42M |
| 461 | LRMR | Larimar Therapeutics, Inc. | 501.75M | -0.82% | 1,766,915 | - |
| 462 | CATX | Perspective Therapeutics, Inc. | 499.03M | 3.06% | 770,600 | 884.00K |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 498.77M | 1.14% | 685,023 | 85.21M |
| 464 | CTNM | Contineum Therapeutics, Inc. | 494.70M | 2.16% | 1,154,003 | - |
| 465 | VREX | Varex Imaging Corporation | 493.81M | 0.34% | 158,256 | 854.40M |
| 466 | STRO | Sutro Biopharma, Inc. | 493.21M | 3.44% | 315,495 | 102.48M |
| 467 | ANL | Adlai Nortye Ltd. | 488.93M | -15.50% | 1,112,308 | 5.40M |
| 468 | KMDA | Kamada Ltd. | 487.87M | -0.24% | 23,044 | 180.46M |
| 469 | MYGN | Myriad Genetics, Inc. | 485.31M | 5.70% | 1,251,942 | 824.50M |
| 470 | ABSI | Absci Corporation | 485.08M | 0.63% | 2,820,265 | 2.80M |
| 471 | IVVD | Invivyd, Inc. | 483.59M | 6.21% | 1,634,319 | 53.43M |
| 472 | PACB | Pacific Biosciences of California, Inc. | 483.20M | 1.91% | 4,352,034 | 160.01M |
| 473 | RGNX | REGENXBIO Inc. | 483.14M | 0.65% | 651,843 | 170.44M |
| 474 | XOMA | XOMA Royalty Corporation | 478.18M | 1.83% | 176,677 | 52.15M |
| 475 | ASMB | Assembly Biosciences, Inc. | 472.87M | 1.26% | 62,139 | 72.30M |
| 476 | AVIR | Atea Pharmaceuticals, Inc. | 468.47M | 1.38% | 244,242 | - |
| 477 | VTVT | vTv Therapeutics Inc. | 468.09M | -1.67% | 38,647 | 17.00K |
| 478 | FLGT | Fulgent Genetics, Inc. | 466.42M | 0.94% | 433,841 | 322.67M |
| 479 | BNTC | Benitec Biopharma Inc. | 465.87M | 2.64% | 175,872 | - |
| 480 | IPSC | Century Therapeutics, Inc. | 465.48M | 9.28% | 1,591,073 | 109.16M |
| 481 | PRLD | Prelude Therapeutics Incorporated | 455.59M | 25.45% | 978,037 | 12.14M |
| 482 | AURA | Aura Biosciences, Inc. | 454.83M | - | 325,529 | - |
| 483 | DNA | Ginkgo Bioworks Holdings, Inc. | 453.43M | 0.91% | 831,332 | 170.16M |
| 484 | KIDS | OrthoPediatrics Corp. | 451.23M | -0.06% | 218,513 | 236.35M |
| 485 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.03M | 2.49% | 57,832 | - |
| 486 | EBS | Emergent BioSolutions Inc. | 447.24M | - | 457,031 | 742.90M |
| 487 | CGC | Canopy Growth Corporation | 446.30M | 5.50% | 11,047,583 | 203.04M |
| 488 | AGL | agilon health, inc. | 446.07M | 18.52% | 329,942 | 5.93B |
| 489 | ALT | Altimmune, Inc. | 442.36M | 3.34% | 2,078,563 | 41.00K |
| 490 | ARMP | Armata Pharmaceuticals, Inc. | 441.79M | -6.37% | 28,780 | 4.90M |
| 491 | PRTC | PureTech Health plc | 440.86M | 2.13% | 3,234 | 6.39M |
| 492 | ANGO | AngioDynamics, Inc. | 430.99M | -1.24% | 528,564 | 313.73M |
| 493 | VNDA | Vanda Pharmaceuticals Inc. | 429.72M | -0.68% | 862,203 | 216.11M |
| 494 | RCKT | Rocket Pharmaceuticals, Inc. | 423.40M | 6.59% | 2,522,364 | - |
| 495 | ENTA | Enanta Pharmaceuticals, Inc. | 422.23M | -0.55% | 108,435 | 66.98M |
| 496 | CYH | Community Health Systems, Inc. | 421.67M | 2.61% | 867,397 | 12.49B |
| 497 | AKBA | Akebia Therapeutics, Inc. | 415.21M | -0.64% | 2,089,700 | 236.20M |
| 498 | CLYM | Climb Bio, Inc. | 413.19M | -2.26% | 830,184 | - |
| 499 | NAUT | Nautilus Biotechnology, Inc. | 411.33M | 6.21% | 280,987 | - |
| 500 | WEAV | Weave Communications, Inc. | 410.55M | 3.98% | 955,021 | 239.02M |